What development phase is 30038Cm in?

30038Cm is FDA-approved (marketed).

What is the generic name of 30038Cm?

MINAPRINE is the generic (nonproprietary) name of 30038Cm.

Last reviewed 2026-04-20 · How we verify

30038Cm (MINAPRINE)

FDA-approved withdrawn Small molecule Quality 10/100

At a glance

Generic name	MINAPRINE
Drug class	minaprine
Target	Acetylcholinesterase, Muscarinic acetylcholine receptor M1, Acetylcholinesterase
Modality	Small molecule
Therapeutic area	Cardiovascular
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

30038Cm CI brief — competitive landscape report
30038Cm updates RSS · CI watch RSS